Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 54 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q2
TODD STRATEGY GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $80,000.00 income
Medicare/Medicaid, Pharmacy
View → Q2
DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Copyright/Patent/Trademark, Budget/Appropriations, Defense, Trade (domestic/foreign)
View → Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
EMPIRE CONSULTING GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View → Q2
W STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $60,000.00 income
Medicare/Medicaid
View → Q2
MILLER STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $60,000.00 income
Medicare/Medicaid, Foreign Relations
View → Q2
THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View → Q2
BOSE PUBLIC AFFAIRS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $10,000.00 income
Health Issues
View → Q2
BGR GOVERNMENT AFFAIRS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy
View → Q2
FARRAGUT PARTNERS LLP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View → Q2
AKIN GUMP STRAUSS HAUER & FELD for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $120,000.00 income
Health Issues, Trade (domestic/foreign), Copyright/Patent/Trademark
View → Q2
LESIC AND CAMPER COMMUNICATIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View → Q2
THORN RUN PARTNERS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View → Q2
CAPITOL COUNSEL LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View → Q2
RADIUS ADVOCACY, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income
Copyright/Patent/Trademark, Pharmacy
View → Q2
CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q2
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View → Q2
ARNOLD & PORTER KAYE SCHOLER LLP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $380,000.00 income
Health Issues
View → Q2
BRAVO GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View → 2A
EAST END GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $75,000.00 income
Health Issues
View → Q2
EAST END GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $75,000.00 income
Health Issues
View → Q2
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View → Q2
MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q2
YC CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q2
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy, Trade (domestic/foreign)
View →
Page 1 of 3 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem